Early risk study for relatives of IBD patients
Part of Digestive system clinical trials.
This study looks at healthy family members of people with Crohn's disease or ulcerative colitis to find early signs of these conditions before symptoms appear. It may help doctors predict and prevent inflammatory bowel disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a close relative (child or sibling) of someone with Crohn's disease or ulcerative colitis
- You must be between 0 and 55 years old
- You must not have been diagnosed with inflammatory bowel disease or have symptoms like ongoing belly pain or diarrhea
- You must not have taken antibiotics in the last 3 months
- You must be generally healthy with no current digestive complaints
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have a parent, sibling, or child with Crohn's disease or ulcerative colitis to help understand why some family members develop the condition. If you are 14 or older and do not already have IBD, you may be able to join.
This study follows close family members of people with Crohn's disease to see if they develop early signs of the condition. It uses blood tests and checkups to detect Crohn's earlier.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
This trial looks at early signs of inflammatory bowel disease (IBD) in adults who have had stomach or bowel symptoms for at least 3 weeks. It aims to understand how the disease progresses.
This study looks at cardiovascular risks in people with inflammatory bowel disease (IBD), like ulcerative colitis or Crohn's disease. It may help understand how IBD affects heart health.
This study follows patients with inflammatory bowel disease (Crohn's or ulcerative colitis) to better understand abnormal growths in the colon (dysplasia) and their risk of turning into cancer. It aims to improve how we predict and prevent cancer in IBD patients.
Hear when a new Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.